BMO reiterates Nike stock Underperform rating on turnaround concerns
BMO Capital reiterated an Underperform rating on Nike (NKE) with a $25.00 price target, citing concerns about the company's turnaround. Nike outlined financial targets for fiscal 2031, including a 12-14% EBIT margin and low single-digit sales growth. The stock is down over 42% year-to-date, trading at $35.85. Analysts have mixed ratings, with some expressing concerns about margin pressures and declining earnings.
How this was made
The 30-second read
Why it matters
BMO’s reiteration frames the investor-day plan as hard to underwrite without clearer product specifics and market stabilization, which can keep valuation and estimate revisions under pressure.
Market read
For traders, the actionable signal is the persistence of bearish sell-side positioning tied to turnaround credibility, not a new Nike operational datapoint.
What to watch
The article emphasizes limited roadmap detail, but it does not quantify how quickly product stabilization could translate into fiscal 2028 results, which may be the key swing factor for near-term estimates.
Background
Nike held an investor day outlining fiscal 2031 EBIT margin and sales growth targets, while also guiding fiscal 2028 sales and EPS down year over year.
Ticker impact
BMO reiterated an Underperform rating on Nike after its investor day, citing turnaround concerns and limited product-roadmap visibility.
Likely downside bias as the market weighs the credibility of the longer-dated targets versus near-term guidance cuts.
The article is centered on a fresh analyst reiteration tied to investor-day disclosures, with specific concerns about de-risking projections and product detail visibility.
Market effects
Adds to the apparel sector narrative that margin recovery timelines may be extended, reinforcing cautious positioning in discretionary retail/athletic wear.
No specific regional catalyst beyond US-listed sentiment.
Limited, as the driver is company-specific analyst positioning rather than a global macro shock.
Counterpoint
Nike’s investor-day targets include a multi-year sales and EPS path, and some banks (e.g., BTIG) stayed Buy, suggesting upside if investors gain confidence in execution.
Key entities
- companyNike Inc.
Subject of the analyst reiteration and investor-day turnaround targets and guidance.
- analyst_firmBMO Capital Markets
Reiterated Underperform rating and set a $25 price target after the investor day.



